Total Payments
$4,383
2024 Payments
$599.21
Companies
44
Transactions
209
Medicare Patients
1,767
Medicare Billing
$171,060
Payment Breakdown by Category
Food & Beverage$3,812 (87.0%)
Education$570.34 (13.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,812 | 197 | 87.0% |
| Education | $570.34 | 12 | 13.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $963.94 | 42 | $0 (2024) |
| ABBVIE INC. | $398.84 | 14 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $317.07 | 13 | $0 (2024) |
| PFIZER INC. | $307.94 | 19 | $0 (2023) |
| Merck Sharp & Dohme LLC | $210.10 | 11 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $198.54 | 10 | $0 (2024) |
| Janssen Biotech, Inc. | $164.34 | 9 | $0 (2021) |
| Ferring Pharmaceuticals Inc. | $158.85 | 10 | $0 (2024) |
| COLOPLAST CORP | $127.50 | 7 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $119.88 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $599.21 | 25 | Ferring Pharmaceuticals Inc. ($98.01) |
| 2023 | $812.14 | 33 | AstraZeneca Pharmaceuticals LP ($185.41) |
| 2022 | $562.55 | 24 | SANOFI-AVENTIS U.S. LLC ($89.00) |
| 2021 | $459.26 | 22 | Astellas Pharma US Inc ($190.48) |
| 2020 | $345.12 | 19 | Coloplast Corp ($52.64) |
| 2019 | $698.16 | 31 | Astellas Pharma US Inc ($259.70) |
| 2018 | $381.84 | 23 | PFIZER INC. ($65.16) |
| 2017 | $524.45 | 32 | Astellas Pharma US Inc ($169.76) |
All Payment Transactions
209 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: ONCOLOGY | ||||||
| 12/11/2024 | DENTSPLY IH AB | LOFRIC (Device) | Food and Beverage | In-kind items and services | $52.78 | General |
| Category: Medical Urology | ||||||
| 12/04/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $33.51 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/06/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2024 | C. R. Bard, Inc. & Subsidiaries | Bard Urinary Drainage Bag (Device) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Urology | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $29.62 | General |
| Category: Oncology | ||||||
| 09/12/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Oncology | ||||||
| 08/29/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: UROLOGY | ||||||
| 07/31/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: Oncology | ||||||
| 07/17/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: ONCOLOGY | ||||||
| 07/10/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: UROLOGY | ||||||
| 06/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Oncology | ||||||
| 06/13/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: ONCOLOGY | ||||||
| 05/22/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Oncology | ||||||
| 05/15/2024 | COLOPLAST CORP | Luja Coude (Device) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Continence Care | ||||||
| 05/03/2024 | Ferring Pharmaceuticals Inc. | CLENPIQ (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/18/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: Oncology | ||||||
| 04/11/2024 | Merck Sharp & Dohme LLC | BRIDION (Drug) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: NEUROSCIENCE | ||||||
| 04/04/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: UROLOGY | ||||||
| 03/27/2024 | Innovation Technologies Inc | IRRISEPT (Device) | Food and Beverage | In-kind items and services | $46.28 | General |
| Category: JET LAVAGE DEVICE WITH CHG | ||||||
| 03/15/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: UROLOGY | ||||||
| 03/13/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Oncology | ||||||
| 02/28/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: ONCOLOGY | ||||||
| 02/22/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $29.94 | General |
| Category: Oncology | ||||||
| 02/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $27.43 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 357 | 556 | $100,063 | $34,688 |
| 2022 | 5 | 425 | 647 | $116,751 | $38,899 |
| 2021 | 7 | 499 | 845 | $150,473 | $56,267 |
| 2020 | 5 | 486 | 733 | $111,095 | $41,207 |
Total Patients
1,767
Total Services
2,781
Medicare Billing
$171,060
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 244 | 421 | $54,887 | $27,035 | 49.3% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 87 | 109 | $34,008 | $6,239 | 18.3% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 12 | 12 | $8,660 | $1,089 | 12.6% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 14 | 14 | $2,508 | $325.13 | 13.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 225 | 369 | $47,454 | $24,181 | 51.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 47 | 83 | $19,635 | $6,749 | 34.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2022 | 83 | 106 | $33,072 | $5,942 | 18.0% |
| 55700 | Biopsy of prostate gland | Facility | 2022 | 14 | 14 | $4,018 | $1,277 | 31.8% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2022 | 16 | 16 | $868.00 | $381.81 | 44.0% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 40 | 59 | $11,704 | $368.08 | 3.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 220 | 393 | $51,384 | $27,445 | 53.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 67 | 153 | $36,567 | $13,751 | 37.6% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Facility | 2021 | 83 | 111 | $34,632 | $6,062 | 17.5% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2021 | 16 | 25 | $13,000 | $4,062 | 31.2% |
| 55700 | Biopsy of prostate gland | Facility | 2021 | 19 | 19 | $5,453 | $1,830 | 33.6% |
| 52310 | Removal of foreign body, stone, or stent from bladder canal (urethra) or bladder using an endoscope | Facility | 2021 | 11 | 12 | $3,984 | $1,407 | 35.3% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2021 | 57 | 106 | $2,968 | $740.88 | 25.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 11 | 11 | $715.00 | $579.15 | 81.0% |
| 76872 | Ultrasound of pelvic region through rectum | Facility | 2021 | 15 | 15 | $1,770 | $390.15 | 22.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 230 | 375 | $33,885 | $19,915 | 58.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 72 | 118 | $24,072 | $8,971 | 37.3% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Facility | 2020 | 74 | 100 | $31,200 | $5,401 | 17.3% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2020 | 19 | 27 | $14,040 | $4,310 | 30.7% |
| 55700 | Biopsy of prostate gland | Facility | 2020 | 16 | 16 | $4,592 | $1,637 | 35.6% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2020 | 59 | 81 | $2,106 | $565.63 | 26.9% |
About Dr. Michael Parker, MD
Dr. Michael Parker, MD is a Urology healthcare provider based in Lewiston, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356382964.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Parker, MD has received a total of $4,383 in payments from pharmaceutical and medical device companies, with $599.21 received in 2024. These payments were reported across 209 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($3,812).
As a Medicare-enrolled provider, Parker has provided services to 1,767 Medicare beneficiaries, totaling 2,781 services with total Medicare billing of $171,060. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Lewiston, ME
- Active Since 06/08/2006
- Last Updated 07/04/2011
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1356382964
Products in Payments
- XTANDI (Drug) $411.50
- LYNPARZA (Drug) $210.76
- Xtandi (Drug) $207.62
- BOTOX (Biological) $171.04
- Nubeqa (Drug) $163.43
- BRIDION (Drug) $157.03
- GEMTESA (Drug) $140.95
- Lupron Depot (Drug) $138.10
- JEVTANA (Drug) $108.71
- Cysview (Drug) $106.20
- ADSTILADRIN (Biological) $81.98
- ERLEADA (Drug) $80.46
- TOVIAZ (Drug) $79.55
- LUPRON DEPOT (Drug) $73.49
- Prolia (Biological) $73.07
- FASLODEX (Drug) $72.10
- Myrbetriq (Drug) $71.89
- ELIGARD (Drug) $69.95
- (815) Thiola (Drug) $68.92
- Erleada (Drug) $55.89
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Lewiston
Dr. Evan Dunn, M.d, M.D
Urology — Payments: $9,011
Urology $9,011
Dr. Christopher Henry, Md, MD
Urology — Payments: $7,213
Urology $7,213
Christopher Foote, D.o, D.O
Urology — Payments: $3,651
Urology $3,651
Dr. Jordan Kurta, Md, MD
Urology — Payments: $2,129
Urology $2,129
Paul Mailhot, Md, MD
Urology — Payments: $59.33
Urology $59.33
David Pakula, Md, MD
Urology
Urology